Chandigarh, [Insert Date] – The second day of the 4th Postgraduate International Vaccinology Course (PGIVAC 2025), organized by PGIMER’s Department of Community Medicine and School of Public Health, delved into vaccine immunology, safety monitoring, and immunization strategies for high-risk populations, featuring insights from global and national experts.

Key Highlights of PGIVAC 2025 Day 2:

✔ Vaccine Immunology & Immune Response

• Dr. Biman Saikia & Dr. Ritu Aggarwal (PGIMER) explained immune response mechanisms and lab assessments.
• Dr. Vipin Vashishtha discussed durability of vaccine-induced immunity.
• Dr. Adam Finn (UK) shared breakthroughs in mucosal and antibody-independent immunity.

Vaccination Strategies for High-Risk Groups

• Senior PGIMER faculty (Drs. Sanjay Verma, Vikas Suri, Rimpi Singla) covered immunization in children, pregnant women, and immunocompromised adults.
• Interactive case studies addressed real-world challenges.

  (AEFI) & Surveillance

• Dr. Deepak Polpakara (MoHFW), Dr. Madhava Ram Balakrishnan (WHO Geneva), and Dr. Manjeet Singh (Chandigarh) highlighted AEFI monitoring, causality assessment, and local experiences.
• Dr. Manmeet Kaur emphasized community advocacy for new vaccine introduction.

The day concluded with a participant feedback session led by Course Director Dr. Madhu Gupta.

Vaccine Immunology : Why PGIVAC 2025 Matters?

With global collaborations and evidence-based discussions, PGIVAC reinforces India’s leadership in vaccinology and public health innovation. The course continues with more expert-led sessions this week.